ambrisentan
CHEBI:CHEBI_135949
Chemical Information
- Molecular Formula
- C22H22N2O4
- Molecular Mass
- 378.422
- Charge
- 0
- SMILES
- C([C@H](OC=1N=C(C)C=C(N1)C)C(O)=O)(OC)(C2=CC=CC=C2)C3=CC=CC=C3
- InChI
- InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1
- InChIKey
- OUJTZYPIHDYQMC-LJQANCHMSA-N
Alternative Names
- letairis
- LU 208075
- LU208075
- volibris
Drug Classification
-
diarylmethaneView Class →
CHEBI:51614
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- DRON_00010000
- 358274
- oboInOwl#hasDbXref
- Drug_Central:4337
- core#notation
- CHEBI:135949
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 358274
- generic_name
- Ambrisentan
- brand_name
- Letairis
- brand_name_base
- Letairis
- oboInOwl#hasDbXref
- Drug_Central:4337
- oboInOwl#id
- CHEBI:135949
- product_type
- BULK INGREDIENT
- marketing_category
- EXPORT ONLY
- listing_expiration_date
- 20241231
- dosage_form
- POWDER
- labeler_name
- Medichem Manufacturing (Malta) Ltd.
- marketing_start_date
- 20100323
- product_ndc
- 69097-387
- application_number
- ANDA210701
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#2_STAR
- route
- ORAL
- spl_id
- fa986fe6-b59e-1b85-c60b-632e2aaf813d
- package_ndc
- 69097-387-19
- package_description
- 1 BLISTER PACK in 1 CARTON (69097-387-19) / 10 TABLET, FILM COATED in 1 BLISTER PACK
- core#notation
- CHEBI:135949
- rxcui
- 722124
- active_ingredient_strength
- 75 kg/75kg
- manufacturer_name
- Cipla USA Inc.
- package_marketing_start_date
- 15-JUN-19
- pharm_class_epc
- Endothelin Receptor Antagonist [EPC]
- pharm_class
- Endothelin Receptor Antagonists [MoA]
- pharm_class_moa
- Endothelin Receptor Antagonists [MoA]
- active_ingredient_name
- AMBRISENTAN
- unii
- HW6NV07QEC
- spl_set_id
- 0e3e3320-27ac-404f-9f01-3d82696e768a
- nui
- N0000175364
- upc
- 0382009141305
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- has_treatment
- http://purl.obolibrary.org/obo/DOID_6432
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect4954
- owl#annotatedSource
- t108686
- owl#someValuesFrom
- t985705